Company registration number 15539304 (England and Wales)
ELIXIR MIDCO LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
ELIXIR MIDCO LIMITED
COMPANY INFORMATION
Directors
K Grover
(Appointed 6 June 2024)
S Packham
(Appointed 6 June 2024)
Company number
15539304
Registered office
Uncommon
I Long Lane
London
SE1 4PG
England
Auditor
HW Fisher Audit
Acre House
11-15 William Road
London
NW1 3ER
United Kingdom
ELIXIR MIDCO LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3
Directors' responsibilities statement
4
Independent auditor's report
5 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 15
ELIXIR MIDCO LIMITED
STRATEGIC REPORT
FOR THE PERIOD ENDED 31 MARCH 2025
- 1 -

The directors present the strategic report for the period ended 31 March 2025.

Review of the business

The Group's business derives from the trade of its subsidiaries Alchemist Learning and Development Limited and Rain Group LLC. Alchemist Group, specialises in the delivery of innovative learning and development solutions for leadership and sales training. Horizon Capital made a strategic investment in the Group in June 2024 and represents the largest shareholder. The investment is Horizon’s first strategic move into the global Training Industry, with Alchemist Group being the platform for future acquisitions. The first of these was completed 5 months later, with the purchase of RAIN Group, a US based sales training company, at the beginning of November 2024.

Group Turnover was £10,764,269 generated from training related activities across companies in the UK, US, Australia and Dubai. Loss before tax was £5,779,820. Revenue grew across both business in this period, though was impacted to some extent in the second half of the year by the global uncertainty caused by US tariffs. However, a number of global businesses who delayed decision making during this period only did so for a brief period and we have seen a return to consistent growth.

Both Alchemist & RAIN continue to see a trend towards more face-to-face training interventions, although virtual & hybrid delivery continues to be a key revenue stream. We have also seen continued growth in the wider digital & design capabilities of the business, as customers seek more innovative, blended approaches through gamification and simulation. We have seen a significant rise in the interest of the role AI plays in learning with our customers this year; The Group is well placed to leverage AI interventions into our existing technology-enabled learning journeys; The initial strategic focus as the period ended is on deploying our enterprise-grade conversational AI solution to sales organisations, and developing new solutions as part of our FY26 product roadmap.

The directors expect to see additional revenue from cross selling between Alchemist and RAIN brands, as well as further acquisitions added to the Group in the current year, which will drive both organic and inorganic revenue and profit growth.

Principal risks and uncertainties

There are a number of risks affecting the business

- Economic risk - The current economic outlook is affecting business performance and confidence in some sectors, such as Energy and Retail, which has delayed or reduced spend on training in some instances. However, we have seen benefit from this as our sales training solutions allow customers in depressed or slower sectors to enhance revenue & performance

- Technology risk - The Group deploys much of its training via its in-house learning management system (LMS). While this platform has received significant investment and we believe it to be robust, as recently reported cases have shown, the cyber threat to all systems is increasing and a real concern. Further investments in talent and enhanced security are planned.

The Group maintains a Risk Register, which is circulated and reviewed by the Board each quarter.

Key performance indicators

Our blended learning solutions delight our customers, as demonstrated by our high volume of repeat business. We gather client and learner feedback on all our programs, and monitor this data to maintain and improve the high quality of our deliveries.

Our global employees are key to the success of the business and we run annual employee engagement surveys to ensure that we continue to have a motivated work force who feel listened to, valued and appropriately rewarded.

The business monitors its key financial indicators which include Revenue, Margin, EBITDA and cash generation. We also monitor the value of secured future revenue that we carry at any point in time, for both the current financial year and for those contracts that roll forward into the next financial year and beyond. Financial results are compared to budget and the prior year, with variances investigated and explanations provided to the Board on a monthly basis.

ELIXIR MIDCO LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 2 -

On behalf of the board

K Grover
Director
1 December 2025
ELIXIR MIDCO LIMITED
DIRECTORS' REPORT
FOR THE PERIOD ENDED 31 MARCH 2025
- 3 -

The directors present their annual report and financial statements for the period ended 31 March 2025.

Principal activities

The principal activity of the company continued to be that of a holding company.

Results and dividends

The results for the period are set out on page 8.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the period and up to the date of signature of the financial statements were as follows:

K Grover
(Appointed 6 June 2024)
S Packham
(Appointed 6 June 2024)
T Maizels
(Appointed 4 March 2024 and resigned 6 June 2024)
M Morris
(Appointed 4 March 2024 and resigned 6 June 2024)
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
K Grover
Director
1 December 2025
ELIXIR MIDCO LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE PERIOD ENDED 31 MARCH 2025
- 4 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent;

- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

ELIXIR MIDCO LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ELIXIR MIDCO LIMITED
- 5 -
Opinion

We have audited the financial statements of Elixir Midco Limited (the 'company') for the period ended 31 March 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the period then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

- the information given in the strategic report and the directors' r eport for the financial period for which the financial statements are prepared is consistent with the financial statements; and

- the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

ELIXIR MIDCO LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ELIXIR MIDCO LIMITED (CONTINUED)
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identifie d material misstatements in the strategic report or the directors' r eport.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

- the financial statements are not in agreement with the accounting records and returns; or

- certain disclosures of remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' r esponsibilities s tatement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

As part of our planning process:

- We enquired of management the systems and controls the company has in place, the areas of the financial statements that are most susceptible to the risk of irregularities and fraud, and whether there was any known, suspected or alleged fraud. The company did not inform us of any known, suspected or alleged fraud.

- We obtained an understanding of the legal and regulatory frameworks applicable to the company. We determined that the following were most relevant: FRS 102, Companies Act 2006 and Tax Law.

- We considered the incentives and opportunities that exist in the company, including the extent of management bias, which present a potential for irregularities and fraud to be perpetuated, and tailored our risk assessment accordingly.

- Using our knowledge of the company, together with the discussions held with the company at the planning stage, we formed a conclusion on the risk of misstatement due to irregularities including fraud and tailored our procedures according to this risk assessment.

The key procedures we undertook to detect irregularities including fraud during the course of the audit included:

- Identifying and testing journal entries and the overall accounting records, in particular those that were significant and unusual.

- Reviewing the financial statement disclosures and determining whether accounting policies have been appropriately applied.

- Reviewing documentation such as the company board minutes, for discussions of irregularities including fraud.

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements even though we have properly planned and performed our audit in accordance with auditing standards. The primary responsibility for the prevention and detection of irregularities and fraud rests with the directors.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

ELIXIR MIDCO LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ELIXIR MIDCO LIMITED (CONTINUED)
- 7 -

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Dean Stevens (Senior Statutory Auditor)
For and on behalf of HW Fisher Audit, Statutory Auditor
Chartered Accountants
Acre House
11-15 William Road
London
NW1 3ER
United Kingdom
1 December 2025
ELIXIR MIDCO LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 31 MARCH 2025
- 8 -
Period
ended
31 March
2025
Notes
£
Turnover
-
Profit before taxation
-
0
Tax on profit
5
-
0
Profit for the financial period
-
0

The profit and loss account has been prepared on the basis that all operations are continuing operations.

ELIXIR MIDCO LIMITED
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 9 -
2025
Notes
£
£
Fixed assets
Investments
6
25,673,107
Current assets
Debtors
8
4,150,118
Creditors: amounts falling due within one year
9
(4,263,225)
Net current liabilities
(113,107)
Total assets less current liabilities
25,560,000
Capital and reserves
Called up share capital
10
25,560,000

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 1 December 2025 and are signed on its behalf by:
K Grover
Director
Company registration number 15539304 (England and Wales)
ELIXIR MIDCO LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 MARCH 2025
- 10 -
Share capital
Notes
£
Balance at 4 March 2024
-
0
Period ended 31 March 2025:
Profit and total comprehensive income
-
Issue of share capital
10
25,560,000
Balance at 31 March 2025
25,560,000
ELIXIR MIDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
- 11 -
1
Accounting policies
Company information

Elixir Midco Limited is a private company limited by shares incorporated in England and Wales. The registered office is Uncommon, I Long Lane, London, England, SE1 4PG.

1.1
Reporting period

The accounting period runs from 4 March 2024 to 31 March 2025. This is due to the company being incorporated on 4 March 2025. There are no comparative figures.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. T he company has therefore taken advantage of e xemptions from the following disclosure requirements:

- Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

- Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’: Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

- Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

The financial statements of the company are consolidated in the financial statements of Elixir Topco Limited. These consolidated financial statements are available from Companies House.

1.3
Going concern

The company is a holding company for a number of trading companies who provide the cash required by the company to meet true its obligations. T he trading subsidiaries have made profits in the year and the directors have reviewed projections and forecasts of the trading entities within the group and are confident that they will continue to be profitable and will be able to meet their own and the company's liabilities as and when they fall due. Accordingly, at the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operation for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

ELIXIR MIDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 12 -
1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

ELIXIR MIDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 13 -
Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Operating profit
2025
Operating profit for the period is stated after charging:
£
Fees payable to the company's auditor for the audit of the company's financial statements
-
0
4
Employees

There were no employees in the current period.

5
Taxation

The actual charge for the period can be reconciled to the expected credit for the period based on the profit or loss and the standard rate of tax as follows:

2025
£
Profit before taxation
-
0
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00%
-
0
Taxation charge in the financial statements
-
ELIXIR MIDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 14 -
6
Fixed asset investments
2025
Notes
£
Investments in subsidiaries
7
25,673,107
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 4 March 2024
-
Additions
25,673,107
At 31 March 2025
25,673,107
Carrying amount
At 31 March 2025
25,673,107
7
Subsidiaries

Details of the company's subsidiaries at 31 March 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Indirect
Elixir Bidco Limited
Uncommon, 1 Long Lane, London, England, SE1 4PG
Ordinary
100.00
-
This is Alchemist (Formerly Alchemist Holdings Limited
Uncommon, 1 Long Lane, London, England, SE1 4PG
Ordinary
0
100.00
Alchemist Learning and Devlopment Limited
Uncommon, 1 Long Lane, London, England, SE1 4PG
Ordinary
0
100.00
Apex Training and Development FZ LLC
Uncommon, 1 Long Lane, London, England, SE1 4PG
Ordinary
0
100.00
This is Alchemist
Uncommon, 1 Long Lane, London, England, SE1 4PG
Ordinary
0
100.00
Elixir US Holdco LLC
68 Harrison Ave, Ste 605, Boston, MA, USA 02111-1929
Ordinary
100.00
-
Elixir US Finco Limited
Uncommon, 1 Long Lane, London, England, SE1 4PG
Ordinary
0
100.00
Elixir US Bidco LLC
68 Harrison Ave, Ste 605, Boston, MA, USA 02111-1929
Ordinary
0
100.00
Rain Group LLC
68 Harrison Ave, Ste 605, Boston, MA, USA 02111-1929
Ordinary
0
100.00
Rain Group Australia PTY
8A 1714 Pittwater Road, Bayview, Sydney, Australia 2104.
Ordinary
0
100.00
8
Debtors
2025
Amounts falling due within one year:
£
Amounts owed by group undertakings
4,150,118
ELIXIR MIDCO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 15 -
9
Creditors: amounts falling due within one year
2025
£
Trade creditors
45,337
Amounts owed to group undertakings
4,143,112
Accruals and deferred income
74,776
4,263,225
10
Share capital
2025
2025
Ordinary share capital
Number
£
Issued and fully paid
Ordinary of £1 each
25,560,000
25,560,000
11
Ultimate controlling party

The ultimate parent undertaking is Elixir Topco Limited, a company incorporated in the United Kingdom. The registered address is Uncommon, 1 Long Lane, London, England, SE1 4PG. The results of Elixir Midco Limited are included within the consolidated financial statements of Elixir Topco Limited. Copies of the group financial statements can be obtained from the UK Registrar of Companies.

2025-03-31 2024-03-04 false false false CCH Software CCH Accounts Production 2024.310 K Grover S Packham T Maizels M Morris 0 15539304 2024-03-04 2025-03-31 15539304 bus:Director1 2024-03-04 2025-03-31 15539304 bus:Director2 2024-03-04 2025-03-31 15539304 bus:Director3 2024-03-04 2025-03-31 15539304 bus:Director4 2024-03-04 2025-03-31 15539304 bus:RegisteredOffice 2024-03-04 2025-03-31 15539304 2025-03-31 15539304 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 15539304 core:CurrentFinancialInstruments 2025-03-31 15539304 core:ShareCapital 2025-03-31 15539304 core:ShareCapital 2024-03-03 15539304 core:ShareCapital 2024-03-04 2025-03-31 15539304 core:UKTax 2024-03-04 2025-03-31 15539304 core:Non-currentFinancialInstruments 2025-03-31 15539304 core:Subsidiary1 2024-03-04 2025-03-31 15539304 core:Subsidiary2 2024-03-04 2025-03-31 15539304 core:Subsidiary3 2024-03-04 2025-03-31 15539304 core:Subsidiary4 2024-03-04 2025-03-31 15539304 core:Subsidiary5 2024-03-04 2025-03-31 15539304 core:Subsidiary6 2024-03-04 2025-03-31 15539304 core:Subsidiary7 2024-03-04 2025-03-31 15539304 core:Subsidiary8 2024-03-04 2025-03-31 15539304 core:Subsidiary9 2024-03-04 2025-03-31 15539304 core:Subsidiary10 2024-03-04 2025-03-31 15539304 1 2024-03-04 2025-03-31 15539304 core:Subsidiary1 1 2024-03-04 2025-03-31 15539304 core:Subsidiary6 1 2024-03-04 2025-03-31 15539304 bus:PrivateLimitedCompanyLtd 2024-03-04 2025-03-31 15539304 bus:FRS102 2024-03-04 2025-03-31 15539304 bus:Audited 2024-03-04 2025-03-31 15539304 bus:FullAccounts 2024-03-04 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP